Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AstraZeneca Cuts 600 U.S. Sales Jobs At Cost-Saving Program Takes Effect
FDA Approves KLYGEFA™ (gefurulimab-gaks), Expanding Treatment Options for Generalized Myasthenia Gravis
AstraZeneca: Alexion's Klygefa Gets EU Approval To Treat Adults With Generalised Myasthenia Gravis
AstraZeneca's Klygefa Gets U.S., E.U. Approval | Morningstar
4,088 AstraZeneca Plc $AZN Shares Purchased by Phoenix Financial Ltd. - Daily Political
Migdal Insurance & Financial Holdings Ltd. Sells 306,000 Shares of AstraZeneca Plc $AZN
Summit Therapeutics Provides Update Regarding Ivonescimab Biologics License Application | Morningstar
Top 3 British Biotech Stocks To Watch In November 2026
Is AstraZeneca (LSE:AZN) Reasonable After Its Oncology Led Cash Flow Push?
AstraZeneca announces FDA approval of imfinzi/EV combination
AstraZeneca (LSE:AZN) Will Transfer Its Primary Listing To The NYSE In 2026
AstraZeneca announces EMA's CHMP recommends approval of Baxfendy
6,304 AstraZeneca Plc $AZN Shares Bought by R Squared Ltd - Zolmax
48,390 Shares in AstraZeneca Plc $AZN Bought by Lido Advisors LLC
AstraZeneca Plc $AZN Stock Purchased by R Squared Ltd - Daily Political
Compugen Ltd (CGEN) Q3 2026 Earnings Call Highlights: Revenue Doubles as Gilead and AstraZeneca ...
AstraZeneca buys STL company
AstraZeneca And 2 Other British Undervalued Stocks To Own
What Compugen (CGEN) Said on Its Q3 Earnings Call - Zolmax
AstraZeneca Plc $AZN Shares Purchased by Kestra Advisory Services LLC - Markets Daily
AstraZeneca Plc $AZN Stake Lowered by Allspring Global Investments Holdings LLC
AstraZeneca to acquire American vaccine developer Omniose | Business News | ArcaMax Publishing
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
AstraZeneca (LSE:AZN) Reaffirms Guidance As Pipeline Strength Keeps Undervaluation In View
AstraZeneca (LSE:AZN) Stock Fair Value Edges Higher After Mixed Analyst Target Changes
AstraZeneca to Acquire Omniose | Morningstar
AstraZeneca Gains Single-Cell Bioconjugation Technology Through Omniose Deal
AstraZeneca Acquires Omniose Following Three-Year Research Collaboration
AstraZeneca bolsters vaccine pipeline with US-biotech Omniose acquisition
AstraZeneca Plc $AZN Stock: M&G PLC Grows Position
7,250 Shares of AstraZeneca Plc $AZN Purchased by CenterBook Partners LP
The Battle for Narrative Sovereignty: Why the Pharmaceutical Industry Collectively Refutes the "AI Will Cure Most Diseases Within a Decade" Claim
Deliverable Innovative Drugs: Thriving in the "Best Era" for Breakthrough Pharmaceutical Development
642,497 AstraZeneca Plc $AZN Shares Bought by M&G PLC - Daily Political
AstraZeneca (LON:AZN) Price Target Raised to £120 - Markets Daily
AstraZeneca (LON:AZN) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says
7,107 Shares of AstraZeneca Plc $AZN Purchased by Mirae Asset Global Investments Co. Ltd.
AstraZeneca Plc $AZN Stock: Ethic Inc. Grows Holdings
Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for AstraZeneca (LON:AZN) Stock - Daily Political
Mirae Asset Global Investments Co. Ltd. Purchases New Stake in AstraZeneca Plc $AZN - Daily Political
AstraZeneca Plc $AZN Stock: Pictet Asset Management Holding SA Cuts Holdings
264,627 AstraZeneca Plc $AZN Shares Sold by Pictet Asset Management Holding SA
3 British Biotech Stocks With P E Under 27 To Watch
US measles status to go up for review
AstraZeneca Plc (NYSE:AZN) Stock Has Average Price Target of $206.67 According to Brokerages
CIIE opens with longtime exhibitors unveiling latest innovations
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $147.00 Price Target at Guggenheim - Daily Political
Following midterm losses, MAHA is at a crossroads
Advancing cancer drug discovery
Our Pick Of The Best British Undervalued Stocks In November 2026
Manufacturing Stocks To Consider - November 5th - Daily Political
HUTCHMED Sees $1 Billion Opportunity as Lung Cancer Combo Advances Toward Approvals - Daily Political
AstraZeneca PLC (LON:AZN) Stock Has Consensus Target Price of £153.57 - Daily Political
Quantifying the human visual exposome with vision language models
Cardiac and vascular involvement in protein misfolding diseases
Democrats get their health agenda ready ahead of takeover
AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
Dow Jones Top Company Headlines at 5 PM ET: Qualcomm Revenue Falls as Handset Slowdown Offsets Automotive Gains | AstraZeneca ... | Morningstar
Rhythm Pharmaceuticals stock surges 28% on AstraZeneca bid report
16,079 Shares of AstraZeneca Plc $AZN Acquired by Provenance Wealth Advisors LLC
The Geography of Clinical Research - Foreign Policy
11,643 Shares of AstraZeneca Plc $AZN Acquired by ARGA Investment Management LP
Research Analysts' Recent Ratings Updates for AstraZeneca (AZN) - Daily Political
AstraZeneca Names Naveen Yamarthi as New India Managing Director, ETGCC
AstraZeneca India appoints new MD and Chennai centre head
Sowell Financial Services LLC Acquires 4,004 Shares of AstraZeneca Plc $AZN - Daily Political
Reply to: 'Interpreting surgical consolidation in oligometastatic gastro-oesophageal cancer'
High Court restrains NPPA from action against AstraZeneca
RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines
Earnings roundup: AstraZeneca's cost cuts, Alnylam's slump and Regeneron's resilience
27,056 AstraZeneca Plc $AZN Shares Acquired by International Assets Investment Management LLC
D.A. Davidson & CO. Sells 7,410 Shares of AstraZeneca Plc $AZN
1,929,102 Shares of AstraZeneca Plc $AZN Acquired by Bank Julius Baer & Co. Ltd Zurich
UK Stock Market Today: FTSE 100 Futures Edge Up As Traders Brace For BoE
SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus
Hutchmed Regulatory Submissions for Orpathys with Tagrisso Accep
AstraZeneca Earnings: Excellent Growth, Three-Year Restructuring Program To Invest in Pipeline | Morningstar
Denosumab in multiple myeloma patients with severe renal impairment: a multicenter phase 2 study
Manufacturing Stocks To Follow Today - November 1st - Daily Political
Cidel Asset Management Inc. Sells 21,125 Shares of AstraZeneca Plc $AZN
AstraZeneca (AZN) Gets a Buy from Bank of America Securities
AstraZeneca (NYSE:AZN) Announces Quarterly Earnings Results, Beats Estimates By $0.19 EPS - Daily Political
AstraZeneca Announces $1.5 Billion Efficiency Drive to Fuel Drug Pipeline Growth, ETPharma
AstraZeneca (NYSE:AZN) Share Price Crosses Above 200 Day Moving Average - Time to Sell?
AstraZeneca (LON:AZN) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?
89,287 AstraZeneca Plc $AZN Shares Sold by Apollon Wealth Management LLC
AstraZeneca (LON:AZN) Given "Buy" Rating at Jefferies Financial Group - Daily Political
Q3 earnings round-up: AstraZeneca, AbbVie, Kenvue
Healthcare Stocks Trade Higher: CDNA Gains 20%, REGN Adds 12%, PROF Climbs 10%, AZN Advances 7%
AstraZeneca Q3 Earnings Call Highlights
AstraZeneca (NYSE: AZN) Core EPS climbs 14% and full-year guidance holds - Zolmax
AstraZeneca Stocks Rise 7.65% With $2 Billion Restructuring Cost Ceiling
AstraZeneca (LON:AZN) Stock Jumps 7% - What's Next?
Best Manufacturing Stocks To Research - October 30th - Zolmax
Learn Why The Bull Case For AstraZeneca Stock Could Change Following Earnings Beat
AstraZeneca (LON:AZN) Stock Rating Reaffirmed as Buy by Jefferies Financial Group - Markets Daily
AstraZeneca news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
